P1558: EARLY-START DEFERIPRONE IN INFANTS/YOUNG CHILDREN WITH TRANSFUSION-DEPENDENT BETA THALASSEMIA: EVIDENCE FOR IRON SHUTTLING TO TRANSFERRIN—RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL (START)
F. Tricta,
C. Fradette,
N. Temin,
A. Rozova,
D. Lee,
I. Cabantchik
Affiliations
F. Tricta
1 Chiesi Canada Corporation, Toronto, Canada
C. Fradette
1 Chiesi Canada Corporation, Toronto, Canada
N. Temin
1 Chiesi Canada Corporation, Toronto, Canada
A. Rozova
1 Chiesi Canada Corporation, Toronto, Canada
D. Lee
1 Chiesi Canada Corporation, Toronto, Canada
I. Cabantchik
2 Alexander Silberman Institute of Life Sciences, Jerusalem, Israel
